Back to Reports

The Acquisitive: Medical Devices M&A Activity Q1 2021

Published: 13 May 2021 Code: GDMED0003M&AQD

Globaldata’s Medical Devices M&A Activity Q1 2021 report provides insights on the medical activity overview, regional medical M&A activity, and medical subsector M&A review.

Significant summary of the medical activity:

As COVID-19 redefines business priorities, it is important for companies to focus not only on the themes that are important for the short-term, but also to invest in themes that will enable them to become more resilient and responsive in the longer term.

The increased importance of healthcare due to the pandemic has seen several major deals driven by themes such as remote patient monitoring.

One of the most significant deals driven by remote patient monitoring is the acquisition of Preventice Solutions by Boston Scientific.

Genetic testing and profiling is an important aspect of precision and personalized medicine. The accuracy and research behind this technology continues to grow while the price continues to decrease. As such, companies are heavily investing in this theme. Roche, Agilent Technologies, and Veracyte acquired companies in this space in Q1 2021.

The COVID-19 pandemic has also prompted companies to strategize and take part in acquisitions that help strengthen and expand their portfolios. STERIS and Roche are examples of such companies that have taken part in COVID-19 driven acquisitions in Q1 2021.

Deal analysis in the medical sector:

  • Deal analysis: STERIS to acquire Cantel Medical, a provider of infection prevention products and services primarily to endoscopy and dental Customers. Roche to Acquire GenMark Diagnostics that is a medical device company that provides clinical testing systems. GenMark develops products used in treatment of an array of infections as well as educational resources to medical professionals. Boston Scientific to Acquire 78% Stake in Preventice Solutions, which is a health care technology company. The company offers mobile healthcare care delivery and remote patient monitoring solutions that connect patients, clinicians, and hospitals
  • Notable cross-border deals announcements:  ICON to acquire PRA Health Sciences USD 12 billion. aJazz Pharma to acquire GW Pharma for USD7.2 billion. SeaSpine to acquire 7D Surgical for USD110 million. Metamaterial acquires specialized lens casting production equipment and intellectual property for USD0.8 million

Download our free report for more detailed insights.

Register below for a copy of your FREE report

 

First name is required
Last name is required
Job Title is required
Company is required
Work email is required
Country is required
Industry is required
 Tick here to opt-out of curated industry news, reports, and event updates from GlobalData
By clicking 'Submit' you agree to our Terms & Conditions and consent to us collecting your details for the purposes of your enquiry.
 

GDPR + CCPA Compliant

Personal & transactional information is kept safe from unauthorized use.

Visit our privacy policy for more information about our services, how we may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Still looking?

Have you explored all of our expert analysis? Uncover your next opportunity with our reports.

Explorer

Access more premium companies when you subscribe to Explorer